MSTN and sarcopenia: Sharp scores (OR = 1.008; 95% CI: 1.002–1.014; P = 0.013) and higher serum myostatin levels (OR = 1.222; 95% CI: 1.015–1.472; P = 0.034) were significant risk factors for sarcopenia in RA patients.